elevated monocyte count
OtherThe monocyte count at admission was higher than 0.445×10*9 cells/L
NCT Number: NCT04390919
To explore the prognostic indicators for patients with ADHF
Looking for future studies?
Notify Me18 year–94 year
All sexes
Observational
According to ESC Guidelines for the diagnosis of acute heart failure 2008, patients with ADHF were diagnosed, and their medical history, laboratory examination and treatment plan were retrospectively analyzed, and the patients were followed up for 1 year. The 1-year outcomes of patients were analyzed to explore the prognostic indicators for patients with ADHF
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The monocyte count at admission was higher than 0.445×10*9 cells/L
Time frame: 1 year
The primary end point was one-year all-cause death
Time frame: 1 year
the secondary end point was one-year HF-related rehospitalization.
Chongqing Medical University
Other
Elevated Blood Monocyte Count Predicts 1 Year Poor Outcomes for Patients Admitted With Acute Decompensated Heart Failure
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06243029
Acute Decompensated Heart Failure, Cardiovascular Diseases
Cambridge, United Kingdom
View Trial DetailsNCT03836079
Acute Decompensated Heart Failure, Acute Heart Failure
Lakewood, Colorado, United States
View Trial DetailsNCT01347567
Acute Decompensated Heart Failure, Cardiovascular Diseases
Herston, Queensland, Australia
View Trial DetailsNCT04855097
Acute Decompensated Heart Failure, Cardiovascular Diseases
Boston, Massachusetts, United States
View Trial Details